BIOTECH ACQUISITION COMPANY - *W EXP 11/30/202 (BIOTW)

CUSIP: G1125A116

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / *W EXP 11/30/202
Total 13F shares
6,652,527
Share change
+100,603
Total reported value
$391,000
Price per share
$0.06
Number of holders
38
Value change
+$5,961
Number of buys
2
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP G1125A116?
CUSIP G1125A116 identifies BIOTW - BIOTECH ACQUISITION COMPANY - *W EXP 11/30/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BIOTECH ACQUISITION COMPANY - *W EXP 11/30/202 (BIOTW) as of Q3 2022

As of 30 Sep 2022, BIOTECH ACQUISITION COMPANY - *W EXP 11/30/202 (BIOTW) was held by 38 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,652,527 shares. The largest 10 holders included HGC Investment Management Inc., Polar Asset Management Partners Inc., ARISTEIA CAPITAL LLC, RAMIUS ADVISORS LLC, Corbin Capital Partners, L.P., Q Global Advisors, LLC, KINGSTOWN CAPITAL MANAGEMENT L.P., Atalaya Capital Management LP, Linden Advisors LP, and Shaolin Capital Management LLC. This page lists 38 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.